Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Central Coast Multispecialty Medical Group, Inc.
FDA Inspection
•Central Coast Multispecialty Medical Group, Inc.•April 14, 2022

Central Coast Multispecialty Medical Group, Inc. – FDA Inspection, Apr 14, 2022

Record Details

This FDA Inspection record concerns Central Coast Multispecialty Medical Group, Inc., with an inspection on April 14, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Central Coast Multispecialty Medical Group, Inc.
Inspection Date
April 14, 2022
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
View Company Profile

ID · fd674a5f-5ae9-45ef-a9fd-bbaaedea490c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1167289
FDA center
Biologics
Project area
Blood and Blood Products

FDA Citations

3
  1. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  2. 21 CFR 1271.85(a)Infection with communicable disease agents
  3. 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Central Coast Multispecialty Medical Group, Inc.

5
DateClassificationOfficeProject area
May 16, 2025OAISan Francisco District OfficeHuman Cellular, Tissue, and Gene Therapies
July 31, 2017NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
June 23, 2015NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
November 2, 2012VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 21, 2010NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Central Coast Multispecialty Medical Group, Inc.
  • FDA Inspection 1270075 - 2025-05-16
  • FDA Inspection 1021255 - 2017-07-31
  • FDA Inspection 931419 - 2015-06-23
  • FDA Inspection 805572 - 2012-11-02
  • FDA Inspection 681494 - 2010-09-21

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Central Coast Multispecialty Medical Group, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.